Synthesis, Molecular Modeling, and Biological Activity of Zinc(II) Salts with 1,4-Bis(benzimidazol-2-yl)benzene

Table 3

¹³C-NMR spectral data of the ligand and complexes (in δ p.p.m).

Compound^a	C-1′	C-2′	C-6′	C-2	C-4	C-5	C-6	C-7	C-8	C-9
L	131.19s	126.92s	126.92s	143.94s	111.41s	121.85s	119.01s	122.81s	143.94s	131.19s
[ZnL2(OCH2CH2CH2CH3)2]	131.17s	126.91s	126.91s	143.92s	111.41s	121.85s	119.00s	122.81s	150.61s	132.17s
	(−0.02)	(−0.01)	(−0.01)	(−0.02)	(0.00)	—	(−0.01)	(0.0)	(6.67)	(0.98)
[Zn(OClO3)2L]HO(CH2)3CH3]	130.25s	127.16s	127.16s	137.50s	114.91s	123.01s	114.91	123.01	149.87s	130.25s
	(−0.84)	(0.24)	(0.24)	(−6.44)	(3.50)	(1.16)	(−4.10)	(0.20)	(5.93)	(−0.94)

^aSpectra recorded in dmso-d₆, s: singlet, d: doublet, t: triplet, m: multiplet, b: broad
∗Values in the parentheses are coordination induced shifts (c.i.s) = 𝛿_complex−𝛿_ligand.